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Abstract
Purpose The aim of the study was to assess whether
hyposalivation is linked with increased thirst sensation and
weight gain in hemodialysis (HD) patients and whether
there is any connection between hyposalivation and sodium
balance.
Methods One hundred and eleven participants (64 males
and 47 females) receiving maintenance hemodialysis, mean
age 59.1 ± 13.6 years old, were involved in the study. All
participants completed a survey evaluating thirst intensity
(DTI) and xerostomia inventory (XI). In addition, pre-
dialysis sodium concentration and inter-dialytic weight
gain (IWG) were assessed. The division into no-hyposali-
vation and hyposalivation groups was based on an
unstimulated whole saliva (UWS) flow rate.
Results Hyposalivation, UWS below 0.1 mL/min, was
reported in 28.8 % of HD patients. In these participants,
IWG was higher than in patients with UWS [ 0.1 mL/min
(3.65 ± 1.78 vs 3.0 ± 1.4; p = 0.042), as well as the pre-
dialysis sodium gradient (3.22 ± 2.1 vs 1.6 ± 2.8;
p = 0.031). The mean XI and DTI scores did not differ
between study groups. In the hyposalivation group, pre-
dialysis sodium serum gradient negatively correlated with
saliva outflow (q = -0.61, p = 0.019) and positively with
IWG (q = 0.49, p = 0.022). IWG correlated with XI
(q = 0.622, p = 0.016) in hyposalivation group and with
DTI in no-hyposalivation group (q = 0.386, p = 0.033).
Conclusions Hyposalivation significantly correlates with
IWG; however, its influence on thirst and self-reported
mouth dryness seems to be weaker than expected. Addi-
tionally, hyposalivation was found to be associated with an
elevated pre-dialysis sodium gradient.
Keywords Hyposalivation  Inter-dialytic weight
gain  Sodium gradient  Thirst score  Xerostomia
inventory
Introduction
Patients with end-stage renal disease treated with inter-
mittent hemodialysis (HD) have to maintain proper fluid
volume balance, which should be achieved by daily
restrictions in fluid consumption [1]. The improper drink-
ing behaviors seen in this group of patients leads to chronic
fluid overload, which may result in uncontrolled hyper-
tension, pulmonary edema or other cardiovascular mani-
festations, and dramatically increase the risk of premature
death [2]. Thus, although inter-dialytic weight gain (IWG)
seems to be an indirect indicator of patients’ adherence to
the renal replacement therapy, it may be modulated by
many factors [3], the foremost being excessive thirst,
probably stimulated by xerostomia (a feeling of a dry
mouth) [4]. In addition, some hemodialysis patients may
demonstrate impaired saliva secretion, which not only
produces an oral cavity environment conducive to caries
associated with changes in oral soft tissue (e.g., mucosal
soreness, gingivitis, cheilitis fissuring of the tongue and
recurrent yeast infections) but may also enhance thirst and
a subjective sensation of a dry mouth [5–10]. Bots et al. [4]
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note that these factors contribute to the intake of fluids and
consequently to excessive IWG in patients on maintenance
hemodialysis.
Additionally, our previous study demonstrates that thirst
and IWG may not be linked with pre- nor post-dialysis
sodium serum concentration, but mainly with pre-dialysis
sodium gradient [11], which makes this factor worthy of
further consideration.
The aim of the study was therefore to determine whether
hyposalivation is really a factor which enhances xerosto-
mia, thirst and weight gain (IWG) in patients on mainte-
nance hemodialysis. The study also tries to establish a
connection between hyposalivation and sodium balance.
Material and method
A prospective trial was conducted in 111 maintenance
hemodialysis patients (64 males and 47 females), mean age
59.1 ± 13.6 years. The mean time from starting hemodi-
alysis was at least 6 months: The mean time being
14.7 ± 8.9 months. All subjects were recruited from the
Dialysis Department of the Norbert Barlicki Memorial
Teaching Hospital No. 1. The mean session time was
253 min. The causes of end-stage renal disease included
chronic glomerulonephritis in 28 patients, diabetic
nephropathy in 40, adult polycystic kidney disease in 8,
hypertension in 16, tubulointerstitial nephritis in 6 and
unknown in 13 patients. The eligibility criteria for a patient
to be included into the study were as follows: age between
18 and 80 years old, a fixed hemodialysis schedule of 3
times a week and a stable clinical condition. The exclusion
criteria comprised uncontrolled hypertension or recurrent
symptomatic hypotension episodes, chronic heart failure
(NYHA stage 4), severe acute infections requiring hospi-
talization and the administration of centrally acting sym-
patholytics. All patients were advised to maintain their
usual dietary habits.
Of the participants, two subgroups were formed basing
on the presence of hyposalivation, defined by a salivary
flow rate below 0.1 mL/min [12]. To confirm or exclude
hyposalivation, unstimulated whole saliva (UWS) was
collected for 5 mins through use of the spitting method
before a mid-week HD session. The subject refrained from
eating, tooth brushing, mouth rinsing or smoking for at
least 1 h before spitting. They were seated in upright
position and asked to relax during spitting. The participants
were instructed to avoid swallowing the saliva during
sample collection to allow the saliva to accumulate in the
floor of the mouth and were instructed to spit out into test
tubes every 30 s for 5 mins. The saliva flow rate was then
calculated to milliliters per minute.
All participants also completed a survey evaluating
thirst intensity and xerostomia. The dialysis thirst inventory
(DTI) is a questionnaire which consists of 7 items, while
the validated xerostomia inventory comprises 11 items,
each with a 5-point Likert scale ranging from never (1) to
always (5). The results of the inventories range from a
minimum of 7 and 11 points (no thirst and no dry mouth) to
a maximum of 35 and 55 points (enormous thirst and
extremely dry mouth), respectively. Both questionnaires
were conducted together with the biochemical tests, i.e.,
pre- and post-dialysis serum sodium concentration and
sodium gradient: The difference between serum sodium
and dialysis fluid sodium concentration presented as
absolute numbers. All measurements were carried out
routinely in certified central hospital laboratory automatic
analyzers. Simultaneously, IWG, defined as the difference
between current body mass and dry weight (IWG), and
blood pressure (BP) were measured. All assessments, i.e.,
blood specimens and saliva collection as well as the sur-
vey, were conducted with the principle of the single time
point assessment (a mid-week HD session).
The antihypertensive treatment allowed BP below
140/90 mmHg before and 130/80 mmHg after hemodial-
ysis to be achieved in most of the participants. In both
Table 1 Characteristics of the study group
Hyposalivation No-hyposalivation p value
N 32 79 NS
Males 19 45 NS
Age (years) 59.1 ± 14.2 58.3 ± 13.5 NS
Diabetes (n) 15 31 NS
HbA1c (%) 6.3 ± 0.4 6.4 ± 0.3 NS
Smokers (n) 8 11 NS
Hemodialysis
vintage (months)
13.8 ± 7.2 14.2 ± 6.9 NS
Dialysis session time
(min)
255 ± 20 250 ± 30 NS
kt/V 1.21 ± 0.2 1.22 ± 0.15 NS
Hgb (g/dl) 10.8 ± 1.5 10.7 ± 1.3 NS
Albumins (g/L) 4.0 ± 1.9 3.9 ± 2.1 NS
Residual diuresis (n) 9 17 NS
Volume (mL/day) 740 ± 120 710 ± 110 NS







Dentures (n) 12 26 NS
HbA1c glycosylated hemoglobin type A1c, Hgb hemoglobin
Values are mean ± standard deviation (SD)
NS not significant
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subgroups, antihypertensive treatment was not changed and
doses were stable.
The kidney replacement therapy was conducted on
Fresenius 4008 dialysis machines exclusively. Standard
bicarbonate dialysate fluid containing 140 mmol/L of
sodium, 1.25 mmol/L of calcium and 0.75 mmol/L of
magnesium was used. The potassium concentration varied
depending on the degree of the patient’s kalemia before the
session. The dialysis adequacy was assessed with a single
pooled kT/V of average value 1.2–1.4. The dry weight was
established based on clinical examination, BP measure-
ments and whole body composition spectroscopy [13].
In all participants, the mineral bone disorder associated
with their renal anemia and kidney diseases was success-
fully treated according to KDOQI recommendations [14,
15] as was diabetes mellitus [16]. Both study subgroups
were age and sex matched, and significant parameters were
comparable with regard to the number of participants. The
characteristics of subgroups are summarized in Table 1.
Statistical analysis
The abnormality of distribution was checked by the
Kolmogrov–Smirnov test. Comparisons between the study
subgroups were performed using the Mann–Whitney test.
The Fisher’s exact probability test was used for gender
comparison. Correlations were assessed by Spearman’s
rank correlation coefficient. Associations between IWG
and pre-, post-dialysis sodium gradient or serum concen-
tration, xerostomia, thirst score, and hyposalivation were
estimated by using generalized linear regression with a
compound symmetry covariance structure.
Differences were considered significant if p was less
than 0.05. The results were expressed as mean ± standard
deviation. Statistical analysis was performed using Statis-
tica for Windows software (version 10.0).
The study was conducted in compliance with the prin-
ciples of the Helsinki Declaration. The study protocol was
approved by the Medical University of Lodz Bioethics
Committee, Resolution Number RNN 147/09/KE.
According to principles of GCP, informed consent was
obtained from all patients prior to their inclusion in the
study.
Results
Saliva flow rate and IWG
The mean unstimulated salivary flow was 0.31 ± 0.28 mL/
min. Hyposalivation (UWS \ 0.1 mL/min) was reported in
28.8 % of HD patients. A statistically significant difference
was seen between subgroups with regard to inter-dialysis
weight gain, which was higher in participants with hypo-
salivation (Table 2).
Sodium serum concentration and its gradient
Both patients with and without hyposalivation demon-
strated similar post-dialysis sodium serum concentrations.
Although the pre-dialysis sodium serum concentration was
lower in the subgroup with hyposalivation than the one
without, the differences did not reach statistical signifi-
cance (Table 2). Similarly, although the post-dialysis
sodium gradient in both subgroups did not differ, the pre-
dialysis gradient was significantly higher in the hyposali-
vation subgroup (Table 2).
The pre-dialysis sodium gradient in both subgroups in
comparison with pooled HD patients is presented in Fig. 1.





136.9 ± 2.4 138.3 ± 2.8
Post-dialysis sodium serum
concentration (mmol/L)
138 ± 2.6 138.4 ± 2.2
Pre-dialysis sodium gradient 3.22 ± 2.1* 1.6 ± 2.8*
Post-dialysis sodium gradient 1.9 ± 2.4 1.5 ± 2.2
Thirst score (pts) 17.9 ± 5.9 18.5 ± 6.9
Xerostomia score (pts) 34.1 ± 11.0 31.7 ± 11.3
Inter-dialysis weight gain (kg) 3.65 ± 1.78** 3.0 ± 1.4**
Values are mean ± standard deviation (SD)
* Z = 2. 9, p = 0.0314
** Z = 2.73, p = 0.0424
Fig. 1 The comparison of assessed parameters in subgroups and in
pooled HD patients presented as a graph with logarithmic scale
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In the hyposalivation group, pre-dialysis sodium serum
gradient negatively correlated with saliva outflow (q =
-0.61, p = 0.019) and positively with IWG (q = 0.49,
p = 0.022). In no-hyposalivation subgroup, no correlations
were noted.
Thirst and xerostomia scores
The mean xerostomia score of the study population was
33.1 ± 10.7. No statistically significant differences were
found between the subjects with hyposalivation and the
rest of HD patients (Table 2). The mean DTI score was
18.6 ± 6.21. Interestingly, as with the xerostomia
inventory, the thirst scores showed little variation
between the hyposalivation and no-hyposalivation sub-
groups (Table 2).
The results in both subgroups and in pooled HD patients
are presented on Fig. 1.
Correlations between IWG, xerostomia, thirst
and saliva flow rate
A positive correlation between IWG and xerostomia
(q = 0.341, p = 0.038), as well as a low and positive
correlation between IWG and thirst (q = 0.2, p = 0.041),
were observed in all HD patients.
Although positive correlations between thirst score and
IWG was noted (q = 0.386, p = 0.033) in the no-hypo-
salivation group, no significant correlations were found in
the hyposalivation group, except between IWG and xero-
stomia score (q = 0.622, p = 0.016). No correlations
between unstimulated salivary flow rate and IWG, thirst
inventory or xerostomia score were found, neither in the
whole group of patients nor in the subgroups of patients
with hyposalivation.
Multivariable analysis
In multivariable analysis, pre-dialysis sodium and saliva
flow rate remained significant predictors of IWG. No
interactions were present between other variables and IWG
(Table 3).
Discussion
According to the most recent criteria, impaired saliva
secretion, hyposalivation, is defined as unstimulated sali-
vary flow rates below 0.1 mL per/min [12, 17]. The per-
centage of patients treated with intermittent hemodialysis,
in whom objectively measured hyposalivation was
observed to be 28.8 %, which was lower than that found by
Bots et al. [4] who note decreased salivation in 36.2 % of
cases. However, different criteria were used by these
authors to define hyposalivation, a 0.15 UWS flow rate,
which would have widened the group of patients, and the
subjects of the present study were treated in one center and
lived in one region, in contrast to the multi-center study
performed by Bots et al. [4]. The mean HD vintage time in
our study was relatively shorter than in other studies;
however, the study group was more homogenous in regard
to this parameter range (6–54 months) than in cited refer-
ence (range 3–188 months) [4]. It might be possible that
the relatively short hemodialysis vintage is reflected lower
than in Bots et al. study percentage of HD patients with
hyposalivation. But, on the other hand, according to Bots
et al. [18], after 2 years of follow-up, no change from
baseline for UWS value was noted in patients who
remained on dialysis (0.31 ± 0.19 vs 0.31 ± 0.18 mL/
min). Additionally, in the study by Kho et al. [6], the HD
vintage was shorter than in both of Bots et al. studies (22 vs
35.8 and 33 months) [5, 18], but the mean UWS values in
those trials were comparable.
The percentage of HD patients with hyposalivation is
higher than in general population. Wiener et al. [17]
determined the percentage of older adults with diagnosed
hyposalivation (UWS \ 0.1 mL/min) to be 12.1 %, which
is over two times lower than in participants of our study,
even though the population of older adults (over 70 years
old) is susceptible to reduced saliva production related to
certain medications and chronic conditions.
However, although the mean salivary flow in our study
(0.31 ± 0.28 mL/min) was slightly higher, it was still
comparable with the mean salivary flow rates demonstrated
in Bots et al. (0.30 ± 0.22 mL/min) or Galvada et al.
(0.28 ± 0.16 mL/min) [4, 5]. The unstimulated salivary
flow rate in the present study was close to the value
obtained by Wiener et al. [17] for a population of older
adults (0.4 ± 0.3 mL/min). Our study also seems to
Table 3 Multivariable predictors of excessive weight gain in he-
modialysis patients (whole cohort)
Estimation Odds
ratio
95 % CI p value
Pre-dialysis sodium
serum concentration
-0.06 0.74 0.81–1.11 NS
Post-dialysis sodium
serum concentration
-0.21 0.98 0.59–2.5 NS
Pre-dialysis sodium
gradient
0.96 0.39 0.38–1.5 \0.01
Post-dialysis sodium
gradient
0.06 0.51 0.24–1.11 NS
Thirst score 0.21 0.88 0.12–2.6 NS
Xerostomia score 0.29 1.9 0.85–3.31 NS
Saliva flow rate -1.98 2.2 0.7–4.31 \0.01
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confirm the finding that unstimulated salivary flow rate is
comparable with values for healthy subjects [4, 5]. How-
ever, different results were obtained by Kho et al. Despite
the fact that the average UWS flow rate was very similar to
the values given in the studies mentioned above
(0.30 ± 0.18 mL/min), those authors found it to be sig-
nificantly different to the UWS flow rate of their control
group (0.45 ± 0.25 mL/min) [6].
Xerostomia, defined as the subjective sensation of oral
dryness, is an important condition that significantly
decreases the quality of life (QoL) for 17–29 % of the older
adult population of the USA [19]. Reports of its prevalence
in European countries vary, ranging from 6 % at 50 years
of age and 15 % of those at 65 years of age in the Swedish
population and to more than 30 % of the Hungarian pop-
ulation. In the English population, self-reported xerostomia
was found in 63 % of hospitalized patients [20–22].
However, the prevalence of the sensation of dry mouth is as
high as almost 100 % in patients with Sjo¨gren’s syndrome
and those who are receiving radiation therapy for head and
neck cancers [23]. Xerostomia in patients on maintenance
hemodialysis can be caused by reduced salivary flow sec-
ondary to atrophy and fibrosis of the salivary glands, use of
certain medications, but mainly to the restriction of fluid
intake [24].
Literature data shows that the percentage of HD patients
who suffer from xerostomia is high and ranges between
32.9 and 76.4 % [4–7]. This is in accord with the present
study, in which 71.8 % of the HD patients report having
dry mouth symptoms. Tools such as the xerostomia
inventory (XI) can not only be used to discriminate indi-
viduals with or without self-reported dry mouth, but also
help to assess the severity of xerostomia. The subjective
feeling of dry mouth for HD patients in the present study
(XI = 33.1 ± 10.7) was found to be similar to that of HD
patients according to Bots et al. (XI = 28.3 ± 9.1) [4] and
higher than seen in Teratani et al. (XI = 22.2 ± 7.4 and
XI = 20.6 ± 5.9 [25], in patients who need hemodialysis
owing to diabetic nephropathy and chronic glomerulone-
phritis, respectively). The XI score was also seen to be
higher than for the general population of older adults
described in Wiener et al. (21.7 ± 7.4) [17].
Oral dryness is often accompanied with hyposalivation,
but not always. The present study confirms those of other
authors in the respect that some patients experience a
subjective feeling of dry mouth despite normal, objectively
measured, levels of saliva secretion, whereas others do not
complain about oral dryness, despite objectively diagnosed
hyposalivation [21, 26, 27]. Wiener et al. [17] report that a
total of 70.4 % of the participants in their study group
suffered from hyposalivation, but did not report having
xerostomia. In our study, only 4 of 32 HD patients with
hyposalivation did not report xerostomia, which confirms
that the prevalence of xerostomia in HD patients is more
frequent than in the general population of older adults with
hyposalivation [17]. On the other hand, in our study, only 5
of 76 patients with a salivary flow higher than 0.1 mL/min
reported never having any symptoms of dry mouth.
According to the literature, the sensation of xerostomia
may occur in people who have normal salivary flow rates
because areas of localized mucosal dehydration may exist
in conjunction with normal salivary flow [17]. A literature
search completed over the period of 1980–1999 by Misti-
aen [28] describes the prevalence of thirst to vary from 6 to
95 %, but the most representative studies on relatively
large samples of HD patients report it to be around 85 %.
Of the groups of patients with low thirst scores, 14 %
reported feeling not abnormally thirsty and 15 % never
thirsty. In our study, only one patient reported a DTI score
of 7 (never) for all questions concerning perceived thirst
and 10.81 % with answers hardly ever and never for the
rest of questions (DTI score 8 and 9 in 2 and 5 patients,
respectively). The mean DTI score of the patients
(18.6 ± 6.21) was comparable with that of the patients in
the Bots et al. study (20.3 ± 7.3). This slightly lower value
can be explained by the shorter mean time of treatment of
hemodialysis in our study, which, according the Bots et al.
[4] findings, may influence thirst sensation (patients
[24 months on dialysis reported more thirst—DTI score
21.6 ± 7.1—than patients B24 months on dialysis—DTI
score 18.0 ± 7.4).
The present study investigates whether hyposalivation,
xerostomia or thirst sensation were related to IWG. Similar
to Bots et al., a significant correlation was found between
IWG and thirst, as well as IWG and xerostomia in whole
group of HD patients, and no relationship between UWS
flow rate and IWG was observed. Nevertheless, when the
subjects were divided into groups with and without hypo-
salivation, the average IWG was found to be significantly
higher in patients with hyposalivation, which may suggest
that this factor plays an important role in enhancing weight
gain. It is worth noting that in the hyposalivation subgroup,
only self-reported dry mouth was related to IWG, which
may indicate that mouth dryness dominates over thirst
sensation in HD patients with hyposalivation, and this is
the main reason for frequent fluid intake. As a very low
amount of saliva causes oral mucosa dryness (dehydration),
those patients frequently moisten oral mucosa by sipping
fluids, which may mask the perception of thirst.
However, in the subgroup with a saliva flow rate higher
than 0.1 mL/min, the thirst sensation was the one that
correlated with IWG. Also, other studies confirm that thirst
is related to IWG despite being based on a range of
methodologies involving different answer categories
varying from a dichotomous yes/no answer to 5-point
answer categories or visual analogue scales (VAS) [28].
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Nevertheless, Mistiaen, in a review of published studies
concerning the relationship between thirst and IWG in
hemodialysis patients, underlines that this relationship is
not necessarily as linear as often thought. For example,
patients with high IWG who do not complain of thirst may
drink a lot to prevent thirst, or drink whenever they feel
slightly thirsty. It may also happen that a patient feels very
thirsty but are able to refrain from drinking [28].
Additionally, the concept of an individual sodium set-
point and its kinetics in hemodialysis must be considered in
regard to IWG and thirst or xerostomia. To maintain
osmolar homeostasis, the sodium changes are always
linked with water ingestion, which is of importance in the
determination of the IWG [29]. The sodium water over-
loads must be removed during HD, but in patients with a
lower sodium set-point, this process is probably slower if
not disrupted [30], and ultrafiltrated sodium tends to be
hypotonic, the Gibbs–Donnan effect [31], which implies
that the diffusion process is responsible for final sodium
tuning [32].
Overall, the problem of hyposalivation and associated
xerostomia, thirst or excessive IWG seems to be more com-
plex than previously considered. One could speculate that
lower serum sodium concentration (below 140 mmol/L) and
elevated sodium gradient (over 3 mmol/L) [33, 34], which are
rapidly normalized during hemodialysis session due to ultra-
filtration (pure water removal) and dialysis with 140 mmol/L
sodium in dialysate, which increases serum sodium concen-
tration, can initiate the process of cell dehydration. Once
dehydrated, cells lose their potential to produce body fluids,
including saliva. Martins et al. [35] and Bots et al. [36] confirm
that the saliva of hemodialysis patients is hypertonic in com-
parison with the saliva of healthy people and its contact with
the mucous membranes of the mouth can in fact lead to cell
dehydration rather than moisturization. Our earlier study
demonstrates that the decrease in sodium concentration in
dialysate normalizes sodium gradient and reduces IWG [11]
and should be of interest, whether or not it may have an
influence on saliva secretion.
The major study limitation is its design as an observa-
tional trial, which can describe only associations but does
not provide certain casual relationships.
Conclusion
Hyposalivation is one of the factors which significantly
correlates with IWG. However, its influence on thirst and
mouth dryness, according to survey results, seems to be
weaker than expected. Additionally, hyposalivation was
found to be associated with an elevated pre-dialysis sodium
gradient, which serves to clarify the connection between
decreased saliva production and excessive weight gain in
patients on maintenance hemodialysis, as well as its
underlying cause.
Although those findings potentially introduce new
aspects in the assessment of the hyposalivation etiopatho-
genesis, the implications of our results need to be investi-
gated in future studies.
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